Stage IV Lung Cancer
Also known as: Stage 4 Lung Cancers / Lung Cancer Stage IV / Pulmonary carcinoma cell type unspecified stage IV / Cancer of lung stage IV / Cancer of lung cell type unspecified stage IV / Pulmonary carcinoma stage IV / Carcinoma of lung stage IV / Lung carcinoma stage IV / Lung carcinoma cell type unspecified stage IV / Carcinoma of lung cell type unspecified stage IV / Ca lung stage IV / Lung cancer cell type unspecified stage IV
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11967 | Binimetinib | 1 | Terminated | 1 |
| DB12267 | Brigatinib | 1 | Terminated | 1 |
| DB11791 | Capmatinib | 1 | Recruiting | 1 |
| DB08947 | Iopamidol | 1 | Completed | 1 |
| DB09037 | Pembrolizumab | 1 | Completed | 1 |
| DB08911 | Trametinib | 1 | Recruiting | 1 |
| DB11595 | Atezolizumab | 1 / 2 | Recruiting | 1 |
| DB00958 | Carboplatin | 1 / 2 | Recruiting | 1 |
| DB00530 | Erlotinib | 1 / 2 | Completed | 1 |
| DB00773 | Etoposide | 1 / 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Recruiting | 1 |
| DB08911 | Trametinib | 1 / 2 | Completed | 1 |
| DB11702 | Antineoplaston A10 | 2 | Terminated | 3 |
| DB00530 | Erlotinib | 2 | Completed | 1 |
| DB00947 | Fulvestrant | 2 | Completed | 1 |
| DB00317 | Gefitinib | 2 | Completed | 1 |
| DB11737 | Icotinib | 2 | Unknown Status | 1 |
| DB16216 | Lazertinib | 2 | Not Yet Recruiting | 1 |
| DB11845 | Lucitanib | 2 | Terminated | 1 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB05626 | Retaspimycin | 2 | Terminated | 1 |
| DB15569 | Sotorasib | 2 | Recruiting | 1 |
| DB00853 | Temozolomide | 2 | Active Not Recruiting | 1 |
| DB14776 | Camrelizumab | 3 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 3 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | Not Available | Recruiting | 1 |
| DB12257 | Platinum | Not Available | Recruiting | 1 |